
In the first hours and days of life, some newborns exhibit incessant crying, tremors, and extreme irritability; behind this clinical picture may lie... withdrawal syndrome in babies, a reaction to the sudden cessation of substances to which they were exposed during pregnancy or through breast milk.
The testimonies gathered by healthcare professionals reflect a increase in exposed newborns and describe conditions that require delicate management in neonatology. Although the data that has emerged comes from hospitals in Argentina, the problem and its treatment are of great interest to Spain and the rest of Europe due to its health and social impact.
What it is and how it manifests itself
Neonatal abstinence syndrome occurs when the baby stops receiving substances that were reaching it through the placenta and breast milkWhen this supply is interrupted after childbirth or when breastfeeding is discontinued, the immature organism reacts with withdrawal signs similar to those experienced by adults when they stop consuming.
Among the most frequently repeated signs are described a very high-pitched cry and difficult to console, persistent tremors, sleep and feeding problems, and even seizures in the most severe cases. This clinical picture requires close observation in the crib or incubator and intervention tailored to each newborn's progress.
Experts also point to possible effects associated with prenatal exposure: intrauterine growth retardationLow birth weight or height, smaller head circumference, some facial malformations or alterations of different organs, in addition to consequences in the long-term neurodevelopmentThe variability of the effects depends on the substances involved and the exposure time.
Regarding clinical management, the teams recommend continuous monitoringMaintain a calm environment with minimal stimulation, encourage skin-to-skin contact if possible, and consider medication when necessary. Breastfeeding is discouraged when the mother is actively using drugs. prevent the transfer of substances to the baby.
Overview and health response in Spain and Europe
In maternity wards and pediatric hospitals in Argentina, a upward curve of newborns with abstinence: some centers report up to ten patients per week, and professionals warn that the phenomenon has been growing since 2017. The last official report cited (2022) estimated that between the 5% and 10% of pregnant women They reported illicit drug use, and clinical teams insist that the problem is under-researched and under-resourced.
For the healthcare systems of Spain and the rest of Europe, this reality reinforces the need for a interdisciplinary approach involving obstetrics, neonatology, mental health, toxicology, and social services. Coordination with primary care and the detection of risks during pregnancy help in planning the delivery and the postnatal follow-upprioritizing the well-being of the newborn and the safety of the mother.
Beyond the statistics, medical and family histories illustrate the social dimension of the problem. Caregivers and foster families describe uncontrollable crying, tremors, and anxiety in the first few months, as well as the need for continued support and access to therapies. Community networks are key when assistance is reduced and institutions are overwhelmed. overwhelmed by demand.
Clinical teams also warn of additional challenges such as polyconsumption and the appearance of substances of uncertain composition, which complicates diagnosis and therapeutic response. In response, they emphasize measures already mentioned by professionals: low-stimulation environments, close monitoring, psychosocial support, and the interruption of breastfeeding if drug use persists.
Addressing infant withdrawal syndrome involves reducing prenatal exposure, early detection, strengthening comfort-focused neonatal care, and ensuring support pathways for families; with these pillars, hospitals can mitigate complications and improve the prognosis in a problem that clinical practice already considers a priority.

